auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
iProgen Biotech Inc.Department
National Research Council CanadaAmount
$600.0K
Province
BCType
C
Agreement Number
984807
Purpose
This is part of a CIIP Korea project. It will support the firm to generate a series of novel Antibody Oligo Conjugate (AOC) candidates that target lucrative but untapped therapeutic opportunities, by combining two different biotechnologies: 1) Antibody Drug Conjugate and 2) Oligo Therapeutics. The AOC candidates will be evaluated against important multidimensional variables for successful clinical deployment, including biological activity, stability, ease of production and pharmacokinetics.
iProgen Biotech Inc. × National Research Council Canada
13 grants totalling $2.3M
Canadian International Innovation Program
117 grants totalling $47.6M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| 7423463 Manitoba Ltd. | $600.0K | Canadian International Innovation Progra... |
| Optiwave Systems Inc. | $600.0K | Canadian International Innovation Progra... |
| Canadian Health Solutions Inc. | $600.0K | Canadian International Innovation Progra... |
| Precision Microdynamics Inc. | $600.0K | Canadian International Innovation Progra... |
| Feldan Bio inc. | $600.0K | Canadian International Innovation Progra... |